Cancer, Genomics and Personalised Medicine: Modelling the Future of Oncology

Available now

www.brighttalk.com

The move towards immunotherapies heralds much promise and this is potentially just the beginning. As cancer is understood increasingly not by type but by specific mutation profile, the era of personalised oncological therapies is visible. To explore this topic further, enjoy an exclusive online discussion presented by BrightTALK.